|
1
|
Kohler BA, Ward E, McCarthy BJ, Schymura
MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA and Edwards
BK: Annual report to the nation on the status of cancer, 1975–2007,
featuring tumors of the brain and other nervous system. J Natl
Cancer Inst. 103:714–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostrom QT, Gittleman H, Liao P,
Vecchione-Koval T, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2010–2014. Neuro
Oncol. 19:v1–v88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lipovich L. Johnson R and Lin CY: MacroRNA
underdogs in a microRNA world: Evolutionary, regulatory, and
biomedical significance of mammalian long non-protein-coding RNA.
Biochim Biophys Acta. 1799:597–615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li M, Deng H, Peng H and Wang Q:
Functional nanoparticles in targeting glioma diagnosis and
therapies. J Nanosci Nanotechnol. 14:415–432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai
Y, Wu D, Wang Y, Zhuang Z and Xia H: Increased level of H19 long
noncoding RNA promotes invasion, angiogenesis, and stemness of
glioblastoma cells. J Neurosurg. 2016:129–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan SK, Pastori C, Penas C, Komotar RJ,
Ivan ME, Wahlestedt C and Ayad NG: Serum long noncoding RNA HOTAIR
as a novel diagnostic and prognostic biomarker in glioblastoma
multiforme. Mol Cancer. 17:742018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi J, Wang YJ, Sun CR, Qin B, Zhang Y and
Chen G: Long noncoding RNA lncHERG promotes cell proliferation,
migration and invasion in glioblastoma. Oncotarget.
8:108031–108041. 2007.
|
|
17
|
Bredel M, Bredel C, Juric D, Duran GE, Yu
RX, Harsh GR, Vogel H, Recht LD, Scheck AC and Sikic BI: Tumor
necrosis factor-alpha-induced protein 3 as a putative regulator of
nuclear factor-kappaB-mediated resistance to O6-alkylating agents
in human glioblastomas. J Clin Oncol. 24:274–287. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bredel M, Bredel C, Juric D, Harsh GR,
Vogel H, Recht LD and Sikic BI: Functional network analysis reveals
extended gliomagenesis pathway maps and three novel MYC-interacting
genes in human gliomas. Cancer Res. 65:8679–8689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gill BJ, Pisapia DJ, Malone HR, Goldstein
H, Lei L, Sonabend A, Yun J, Samanamud J, Sims JS, Banu M, et al:
MRI-localized biopsies reveal subtype-specific differences in
molecular and cellular composition at the margins of glioblastoma.
Proc Natl Acad Sci USA. 111:12550–12555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edgar R, Domrachev M and Lash AE: Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bindea G, Mlecnik B, Hackl H, Charoentong
P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and
Galon J: ClueGO: A Cytoscape plug-in to decipher functionally
grouped gene ontology and pathway annotation networks.
Bioinformatics. 25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bindea G, Galon J and Mlecnik B: CluePedia
Cytoscape plugin: Pathway insights using integrated experimental
and in silico data. Bioinformatics. 29:661–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao W, Wang X, Cai Q, Gao S, Wang J and
Zhang P: Knockdown of TRAF4 expression suppresses osteosarcoma cell
growth in vitro and in vivo. Int J Mol Med. 34:1655–1660. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang K, Wang F and Han JJ: TRAF4 promotes
the growth and invasion of colon cancer through the Wnt/β-catenin
pathway. Int J Clin Exp Pathol. 8:1419–1426. 2015.PubMed/NCBI
|
|
27
|
Yang J, Wei D, Wang W, Shen B, Xu S and
Cao Y: TRAF4 enhances oral squamous cell carcinoma cell growth,
invasion and migration by Wnt-β-catenin signaling pathway. Int J
Clin Exp Pathol. 8:11837–11846. 2015.PubMed/NCBI
|
|
28
|
Zhu L, Zhang S, Huan X, Mei Y and Yang H:
Down-regulation of TRAF4 targeting RSK4 inhibits proliferation,
invasion and metastasis in breast cancer xenografts. Biochem
Biophys Res Commun. 500:810–816. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Zhang R, Li P, Liu Y, Qin K, Fa
ZQ, Liu YJ, Ke YQ and Jiang XD: P53-induced microRNA-107 inhibits
proliferation of glioma cells and down-regulates the expression of
CDK6 and Notch-2. Neurosci Lett. 534:327–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Chen XR, Chen FF, Liu Y, Li P,
Zhang R, Yan K, Yi YJ, Xu ZM and Jiang XD: MicroRNA-107 inhibits
U87 glioma stem cells growth and invasion. Cell Mol Neurobiol.
33:651–657. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He J, Zhang W, Zhou Q, Zhao T, Song Y,
Chai L and Li Y: Low-expression of microRNA-107 inhibits cell
apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell
Biol. 45:1962–1973. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji Y, Wei Y, Wang J, Ao Q, Gong K and Zuo
H: Decreased expression of microRNA-107 predicts poorer prognosis
in glioma. Tumour Biol. 36:4461–4466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wolter M, Werner T, Malzkorn B and
Reifenberger G: Role of microRNAs located on chromosome arm 10q in
malignant gliomas. Brain Pathol. 26:344–358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu X, Cai N, Zhi T, Bao Z, Wang D, Liu Y,
Jiang K, Fan L, Ji J and Liu N: MicroRNA-1179 inhibits glioblastoma
cell proliferation and cell cycle progression via directly
targeting E2F transcription factor 5. Am J Cancer Res. 7:1680–1692.
2017.PubMed/NCBI
|
|
35
|
Wang J, Li J, Guo F and Yan Y:
MicroRNA-133a inhibits the malignant behavior of glioma via
downregulation of matrix metallopeptidase 9. Mol Med Rep.
13:3220–3226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sakr M, Takino T, Sabit H, Nakada M, Li Z
and Sato H: miR-150-5p and miR-133a suppress glioma cell
proliferation and migration through targeting membrane-type-1
matrix metalloproteinase. Gene. 587:155–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Li Y and Jiang C: MiR-133b
contributes to arsenic-induced apoptosis in U251 glioma cells by
targeting the hERG channel. J Mol Neurosci. 55:985–994. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li C, Liu Z, Yang K, Chen X, Zeng Y, Liu
J, Li Z and Liu Y: miR-133b inhibits glioma cell proliferation and
invasion by targeting Sirt1. Oncotarget. 7:36247–36254.
2016.PubMed/NCBI
|
|
39
|
Artinian N, Cloninger C, Holmes B,
Benavides-Serrato A, Bashir T and Gera J: Phosphorylation of the
hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP
signaling, resulting in enhanced glioblastoma growth and
invasiveness. J Biol Chem. 290:19387–19401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu Y, Stamenkovic I and Yu Q: CD44
attenuates activation of the hippo signaling pathway and is a prime
therapeutic target for glioblastoma. Cancer Res. 70:2455–2464.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu Y, Lu J, Zhang Z, Zhu L, Dong S, Guo
G, Li R, Nan Y, Yu K, Zhong Y and Huang Q: Amlexanox, a selective
inhibitor of IKBKE, generates anti-tumoral effects by disrupting
the Hippo pathway in human glioblastoma cell lines. Cell Death Dis.
8:e30222017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee Y, Lee JK, Ahn SH, Lee J and Nam DH:
WNT signaling in glioblastoma and therapeutic opportunities. Lab
Invest. 96:137–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
De Robertis A, Valensin S, Rossi M, Tunici
P, Verani M, De Rosa A, Giordano C, Varrone M, Nencini A, Pratelli
C, et al: Identification and characterization of a small-molecule
inhibitor of Wnt signaling in glioblastoma cells. Mol Cancer Ther.
12:1180–1189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rathod SS, Rani SB, Khan M, Muzumdar D and
Shiras A: Tumor suppressive miRNA-34a suppresses cell proliferation
and tumor growth of glioma stem cells by targeting Akt and Wnt
signaling pathways. FEBS Open Bio. 4:485–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang W, Shen C, Li C, Yang G, Liu H, Chen
X, Zhu D, Zou H, Zhen Y, Zhang D and Zhao S: miR-577 inhibits
glioblastoma tumor growth via the Wnt signaling pathway. Mol
Carcinog. 55:575–585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kahlert UD, Maciaczyk D, Doostkam S, Orr
BA, Simons B, Bogiel T, Reithmeier T, Prinz M, Schubert J,
Niedermann G, et al: Activation of canonical WNT/β-catenin
signaling enhances in vitro motility of glioblastoma cells by
activation of ZEB1 and other activators of
epithelial-to-mesenchymal transition. Cancer Lett. 325:42–53. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kaur N, Chettiar S, Rathod S, Rath P,
Muzumdar D, Shaikh ML and Shiras A: Wnt3a mediated activation of
Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Mol Cell Neurosci. 54:44–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Duan R, Han L, Wang Q, Wei J, Chen L,
Zhang J, Kang C and Wang L: HOXA13 is a potential GBM diagnostic
marker and promotes glioma invasion by activating the Wnt and TGF-β
pathways. Oncotarget. 6:27778–27793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kamino M, Kishida M, Kibe T, Ikoma K,
Iijima M, Hirano H, Tokudome M, Chen L, Koriyama C, Yamada K, et
al: Wnt-5a signaling is correlated with infiltrative activity in
human glioma by inducing cellular migration and MMP-2. Cancer Sci.
102:540–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yu JM, Jun ES and Jung JS, Suh SY, Han JY,
Kim JY, Kim KW and Jung JS: Role of Wnt5a in the proliferation of
human glioblastoma cells. Cancer Lett. 257:172–181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hu B, Wang Q, Wang YA, Hua S, Sauvé CG,
Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, et al: Epigenetic
Activation of WNT5A drives glioblastoma stem cell differentiation
and invasive growth. Cell. 167:1281–1295.e18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bhat KP, Salazar KL, Balasubramaniyan V,
Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL,
Kim SH, et al: The transcriptional coactivator TAZ regulates
mesenchymal differentiation in malignant glioma. Genes Dev.
25:2594–2609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yuan J, Xiao G, Peng G, Liu D, Wang Z,
Liao Y, Liu Q, Wu M and Yuan X: MiRNA-125a-5p inhibits glioblastoma
cell proliferation and promotes cell differentiation by targeting
TAZ. Biochem Biophys Res Commun. 457:171–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schiffgens S, Wilkens L, Brandes AA, Meier
T, Franceschi E, Ermani M, Hartmann C, Sandalcioglu IE and Dumitru
CA: Sex-specific clinicopathological significance of novel
(Frizzled-7) and established (MGMT, IDH1) biomarkers in
glioblastoma. Oncotarget. 7:55169–55180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wald JH, Hatakeyama J, Printsev I, Cuevas
A, Fry WHD, Saldana MJ, VanderVorst K, Rowson-Hodel A, Angelastro
JM, Sweeney C and Carraway KL Rd: Suppression of planar cell
polarity signaling and migration in glioblastoma by Nrdp1-mediated
Dvl polyubiquitination. Oncogene. 36:5158–5167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang LL, Sun KX, Wu DD, Xiu YL, Chen X,
Chen S, Zong ZH, Sang XB, Liu Y and Zhao Y: DLEU1 contributes to
ovarian carcinoma tumourigenesis and development by interacting
with miR-490-3p and altering CDK1 expression. J Cell Mol Med.
21:3055–3065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li X, Li Z, Liu Z, Xiao J, Yu S and Song
Y: Long non-coding RNA DLEU1 predicts poor prognosis of gastric
cancer and contributes to cell proliferation by epigenetically
suppressing KLF2. Cancer Gene Ther. 25:58–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
